Author

Peter K. Um

Johns Hopkins UniversityORCID 0000-0001-8215-9493Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Organism:non-human primate· 2 Assay:proteomics· 2 Organism:rat· 2 Research Focus:benchmarking· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

William R. BishaiiD· 3 shared Alex S. BarasiD· 1 shared Amanda R Maxwell· 1 shared Andrés MatosoiD· 1 shared Andrew S PekosziD· 1 shared Bette KorberiD· 1 shared Cheng Ting LiniD· 1 shared Cory F. BraytoniD· 1 shared

Activity by Year

2023-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

William R. BishaiORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MicrobiologybioRxivPreprintJul 17, 2025

Increased vaccine efficacy against tuberculosis with a recombinant BCG overexpressing the STING agonist cyclic di AMP

Dhiraj Kumar Singh, Peter K. Um, Garima Arora…·William R. Bishai

This study evaluates a modified BCG vaccine overexpressing cyclic di-AMP, showing improved protection against TB in rhesus macaques.

1 citation

non-human primateproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintMay 20, 2025

A conserved region T-cell vaccine for Sarbecoviruses

Marta Escarra‐Senmarti, Jacqueline Brockhurst, Amanda R Maxwell…·Maximillian Rosario

This paper presents a T-cell vaccine targeting conserved regions across Sarbecoviruses to provide cross-protection against evolving variants.

DOI 10.1101/2025.05.20.654373

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 15, 2023

Improved bladder cancer antitumor efficacy with a recombinant BCG that releases a STING agonist

Peter K. Um, Monali Praharaj, Kara A. Lombardo…·Trinity Jude Bivalacqua

This study evaluates a recombinant BCG strain that releases a STING agonist, showing improved antitumor efficacy in bladder cancer models compared to wild-type BCG.

10 citations

𝕏 PostBluesky